July/August 2021: Comparing Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir for second-line HIV treatment: Results of the NADIA Trial in Uganda, Kenya, and Zimbabwe

Aug 27, 2021

Article and Study Summary: Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV. Published in: N Engl J Med 2021;385(4):330-341. https://www.nejm.org/doi/full/10.1056/NEJMoa2101609 Authors: Paton NI, Musaazi J, Kityo C, et al. Summary:...

June 2021: Multimonth Dispensing of up to 6 Months of Antiretroviral Therapy in Malawi and Zambia

Jun 28, 2021

Article and Study Summary Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial. Published in: Lancet Glob. Health. 2021;9(5):e628-e638....

May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

May 27, 2021

Article: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Published in: N Engl J Med. 2021;384(18):1705-1718. https://www.nejm.org/doi/full/10.1056/NEJMoa2033400 Authors: Dorman SE, Nahid P, Kurbatova EV, et al. Summary: The Tuberculosis...

April 2021: IMPAACT 2010/VESTED trial evaluates the virological efficacy and safety of ART regimens containing DTG when started in pregnancy

Apr 29, 2021

Article: Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT...

March 2021: Expanded, population-level access to PrEP through the SEARCH study, with a flexible service delivery model, associated with lower HIV incidence among PrEP initiators in rural communities in Kenya and Uganda

Mar 30, 2021

Article: HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda. Published in: PLoS Med. 2021;18(2):e1003492 https://doi.org/10.1371/journal.pmed.1003492 Authors: Koss CA,...

Journal Club